Jennifer Lachey - Net Worth and Insider Trading
Jennifer Lachey Net Worth
The estimated net worth of Jennifer Lachey is at least $6 Million dollars as of 2024-05-06. Jennifer Lachey is the Chief Scientific Officer of Keros Therapeutics Inc and owns about 95,100 shares of Keros Therapeutics Inc (KROS) stock worth over $6 Million. Details can be seen in Jennifer Lachey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer Lachey has not made any transactions after 2022-07-15 and currently still holds the listed stock(s).
Transaction Summary of Jennifer Lachey
Jennifer Lachey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Lachey owns 1 companies in total, including Keros Therapeutics Inc (KROS) .
Click here to see the complete history of Jennifer Lachey’s form 4 insider trades.
Insider Ownership Summary of Jennifer Lachey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2022-07-15 | Chief Scientific Officer |
Jennifer Lachey Latest Holdings Summary
Jennifer Lachey currently owns a total of 1 stock. Jennifer Lachey owns 95,100 shares of Keros Therapeutics Inc (KROS) as of July 15, 2022, with a value of $6 Million.
Latest Holdings of Jennifer Lachey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2022-07-15 | 95,100 | 60.57 | 5,760,207 |
Holding Weightings of Jennifer Lachey
Jennifer Lachey Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Lachey has made a total of 16 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Keros Therapeutics Inc is the sale of 46,034 shares on July 15, 2022, which brought Jennifer Lachey around $1 Million.
Insider Trading History of Jennifer Lachey
- 1
Jennifer Lachey Trading Performance
Jennifer Lachey Ownership Network
Jennifer Lachey Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Jennifer Lachey is the Chief Scientific Officer of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Operating Officer Christopher Rovaldi , and Chief Medical Officer Simon Peter Cooper .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Jennifer Lachey made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante ,
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 80,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,000 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Jennifer Lachey Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Lachey. You might contact Jennifer Lachey via mailing address: C/o Keros Therapeutics, Inc., 99 Hayden Avenue, Suite 120, Building E, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
